DCH
DauchBAI scenario view
RankAlpha Sentiment CodexPost-earnings T+1AI sentiment snapshot
AI commentary
This is an early T+1 earnings follow-up, so the cleanest evidence is the company filing and release rather than broad sell-side digestion. Immediate market reaction was favorable: after a 2026-05-07 anchor close of $5.78, DCH traded up to $6.64 by the 2026-05-08 close, about 14.9% higher, with intraday trading between $5.72 and $6.85. The tone is better after the modest guide lift and synergy framing, but analyst revision evidence is still thin, so this remains more of a cautious post-print monitoring setup than a high-conviction rerating call.
Evidence flagged
No evidence quality warning is currently attached to this memo.
AI events
Dauch reported Q1 2026 sales of $2.38 billion, adjusted EBITDA of $308.5 million, adjusted EPS of $0.34, and raised the top end of full-year sales and adjusted EBITDA guidance to $10.3-$10.8 billion and $1.3-$1.425 billion, respectively, from $10.3-$10.7 billion and $1.3-$1.4 billion prior; the move matters because the stock had been pricing heavy integration skepticism before the release [#8-K-2026-05-08].
The 10-Q said Dauch had about $2.6 billion of liquidity at March 31, 2026, including about $1.0 billion of cash, about $1.5 billion of revolver availability, and no significant debt maturities before 2028, which should help the market tolerate temporary integration and free-cash-flow pressure [#10-Q-2026-05-08].
Management's supplemental deck shows a total annual run-rate cost synergy target of about $300 million, with greater than $100 million targeted by year-end 2026 and about $35 million achieved as of May 8, 2026; if execution holds, DCH can move from transaction-noise to earnings-power discussion.
Recommendation
No formal recommendation provided.

